BIND Therapeutics Initiates Voluntary Chapter 11 Bankruptcy Protection Proceeding
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Stifel Downgrades BIND Therapeutics (BIND) to Hold Following Chapter 11
May 2, 2016 1:12 PM EDTStifel downgraded BIND Therapeutics (NASDAQ: BIND) from Buy to Hold following Chapter 11 filing.
For an analyst ratings summary and ratings history on BIND Therapeutics click here. For more ratings news on BIND Therapeutics click here.
Shares of BIND Therapeutics closed at $1.45 yesterday.
... MoreBIND Therapeutics (BIND) Announces Receipt of Notice of Default
May 2, 2016 6:28 AM EDTBIND Therapeutics (NASDAQ: BIND) disclosed the following on Monday:
Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
On April 26, 2016, the Company received a notice (the Notice) from Hercules Technology III, L.P. (Hercules) asserting that an event of default had occurred under the Companys amended and restated credit facility (as amended, the Credit Facility) with Hercules as lender. Pursuant to the Credit Facility, Hercules extended the... More
